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The activity of antiviral nucleoside analogues like acyclovir is influenced by a number of cellular factors, 
one being the deoxythymidine (dThd) concentration. We therefore analysed the dThd concentration in 
human plasma and skin and in organs of guinea pig, the common experimental animal. High-performance 
liquid chromatography showed low amounts of dThd in human skin, 0.20-1.15 nmol/g, whereas guinea 
pig skin and spleen had 2&30 nmol/g and the concentration in guinea pig plasma was lo-times higher than 
in human plasma. These animals are therefore in this respect less suitable as accurate models for antiviral 
nucleoside activity in humans. 
Deoxythymidine HPLC Tissue concentration 
1. INTRODUCTION 2. MATERIALS AND METHODS 
The primary site of herpes simplex virus infec- 
tion in man is the skin. One therefore needs to 
know about the presence here of naturally occur- 
ring molecules which compete with antiviral drugs. 
A common experimental animal model for the 
assay of antiviral drug efficiency is the guinea pig. 
2.1. Samples 
The activation of a number of modern antiviral 
substances is dependent on viral or cellular deox- 
ythymidine kin&es (dTKs); examples of these 
compounds are acyclovir , bromovinyldeox- 
yuridine and iododeoxyuridine. Addition of the 
natural substrate of dTK, deoxythymidine (dThd), 
decreases the activity of these substances [1,2]. It 
has been shown that the addition of dThd to 
herpes simplex virus-infected cell cultures reverses 
the action of dTK-activated antiviral compounds 
[ 1,3]. Some cell cultures endogenously exhibit high 
levels of intracellular dThd [ 11. 
Male 6-week-old Dunkin-Hartley guinea pigs 
were from J.A. Sahlin, Malmo, Sweden. The 
animals were killed using pentothal, dissected and 
the organs frozen. Human skin was from patients 
at the Department of Plastic Surgery, Karolinska 
Hospital, Stockholm, and immediately frozen at 
- 70°C. The patients were admitted to the hospital 
for the removal of benign birthmarks. The skin 
was extensively washed with 70% alcohol prior to 
removal. The washing procedure did not affect the 
dThd content (not shown). Heparinized blood was 
from healthy humans and the chilled plasma im- 
mediately separated by centrifugation. 
2.2. Reagents 
To obtain a basis for the interpretation of 
animal and clinical data, we have studied the in- 
tracellular levels of naturally occurring dThd in 
selected tissues and in plasma of human and guinea 
pig origin. 
dThd was from Sigma (St. Louis, MO); 
methanol of analytical grade from Riedel-de Haen, 
Hannover; acetonitrile of chromatographic grade 
from Merck, Darmstadt. 
2.3. Chromatography 
High-performance liquid chromatography 
(HPLC) was performed on a liquid chromato- 
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graph (Waters, Milford, MA). Analytical 5 or 
10pm Rad-PAK C18 columns (8 mm 0 x 
100 mm, Waters) were used under conditions 
previously described [l]; 10 mM ammonium 
acetate in water, pH 4.7 : acetonitrile (95.0: 5.0); 
flow rate 2.5 ml/min, ambient temperature; detec- 
tor sensitivity 0.01. 
2.4. Sample preparations 
Ice-cold 1 M perchloric acid (PCA) was added 
to tissue samples, which were subsequently 
disintegrated by Ultraturrax (Janke and Kunkel, 
FRG). After centrifugation the supernatant was 
neutralized with ice-cold 4 M KOH with 0.4 M 
KH2POd. Cell debris and precipitates were re- 
moved by an additional centrifugation and the 
supernatant was loaded on a Sep-Pak Cis cartridge 
141. 
Plasma samples were loaded directly on Sep-Pak 
Cis cartridges (Waters). 
3. RESULTS 
The dThd content was analysed from the skin of 
6 patients undergoing plastic surgery (table 1). On- 
ly low amounts of dThd were found in human 
skin. 
The dThd concentration varied between dif- 
ferent organs of the guinea pigs (table 2). The 
highest concentrations were found in the skin and 
spleen (20.4-30.5 nmol dThd/g wet wt). In the in- 
testine the concentration of dThd was 8.93 nmol/g 
and levels around 3 nmol/g or lower were found in 
the other organs studied. A higher dThd concen- 
tration was found in guinea pig plasma than in 
human plasma: 1.12 pM vs 0.09 $M (not shown). 
Table 1 
dThd concentration of human skin 
Sample [dThd] (nmol/g wet wt) 
1 <0.20 
2 1.09 
3 1.15 
4 <0.20 
5 0.48 
6 <0.20 
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Table 2 
dThd concentration of organs of three guinea pigs 
Organ [dThd] (nmol/g wet wt) 
(range) 
Skin 
Spleen 
Intestine 
Kidney 
Brain 
Liver 
Heart 
Lung 
Eye 
Pancreas 
Adrenal 
20.4 (16.0 -27.6 ) 
30.5 (24.2 -36.8 ) 
8.93 ( 8.40- 9.70) 
1.50 ( 0.95% 1.99) 
1.98 ( 1.09- 2.66) 
0.68 ( 0.67- 0.70) 
2.42 ( 1.77- 3.31) 
3.66 ( 2.54- 5.55) 
2.24 ( 1.97- 2.50) 
2.62 
4.64 ( 3.68- 6.94) 
4. DISCUSSION 
High contents of dThd were found in guinea pig 
skin. The amounts ranged from 16.0 to 
27.6 nmol/g (average 20.4 nmol/g). The dThd 
concentration for guinea pig skin seems to be of 
the order of 20pM. Addition of 10pM dThd to 
herpes simplex-infected human embryonic lung 
fibroblasts increases the 50% virus inhibiting con- 
centration of acyclovir by a factor of approx. 20 
[l]. The high amounts of dThd in guinea pig skin 
indicate that the guinea pig is less suitable as a 
model system for antiviral nucleosides. This is 
especially important for cutaneous herpes treated 
with antiviral substances with a high K,,, value for 
dTK. 
Conflicting reports have appeared about the 
plasma and serum concentrations of dThd in 
healthy humans. Reports utilizing HPLC methods 
have given dThd values of 0.43-0.60 /cM in human 
plasma [5,6]. Others, using radioimmune or 
microbiological assays, have reported lower values 
[7-lo]. Part of the difference may result from 
different procedures for collecting samples. 
dThd may be degraded by deoxynucleoside 
phosphorylase [l l] or phosphorylated by deox- 
ythymidine kinase [12], present in plasma. Fur- 
ther, the HPLC methods were previously utilized 
close to the sensitivity limit. In this paper we uti- 
lized a new Sep-Pak procedure for the purification 
and concentration of the samples, thereby improv- 
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ing the sensitivity of the assay by a factor of 10. 
However, the dThd concentration of 0.09,uM 
found in human plasma is still close to the sen- 
sitivity limit of the improved assay and should be 
interpreted with caution. The dThd concentration 
found in guinea pig plasma was lo-times higher 
than in plasma of humans. Our results are in ac- 
cordance with those of Nottebrock and Then [S] 
who report that rodents have a higher serum dThd 
concentration than other species. These findings 
further point to the unsuitability of guinea pigs as 
test animals. 
Currently we are investigating dThd contents of 
other human organs. Knowledge of the various 
dThd concentrations is of importance when 
treating herpes virus, since infections in different 
organs may require different doses of the antiviral 
drug to overcome 
nucleosides. 
competition from endogenous 
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